These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 21208541

  • 1. [Expression of multiple drug resistance-associated proteins in non-small cell lung cancer tissues and its clinical significance].
    Li C, Hou M, Zhao Y, Zhou Q.
    Zhongguo Fei Ai Za Zhi; 2005 Dec 20; 8(6):523-6. PubMed ID: 21208541
    [Abstract] [Full Text] [Related]

  • 2. Effects of neoadjuvant chemotherapy on the quantitative expression of P-gp, LRP, MRP, GST-π in NSCLC and its clinical significance.
    Xiang F, Yu W, Shen Y, Wu C, Wang Y.
    Zhongguo Fei Ai Za Zhi; 2007 Oct 20; 10(5):398-405. PubMed ID: 21126409
    [Abstract] [Full Text] [Related]

  • 3. [Study on the relationship among multidrug resistance factor expression of lung cancer tissues and clinicopathological characteristics in patients with lung cancer].
    Zhang L, Yang H, Dong D.
    Zhongguo Fei Ai Za Zhi; 2006 Feb 20; 9(1):60-4. PubMed ID: 21144284
    [Abstract] [Full Text] [Related]

  • 4. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Cancer Invest; 2008 May 20; 26(4):344-51. PubMed ID: 18443954
    [Abstract] [Full Text] [Related]

  • 5. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Hepatogastroenterology; 2008 May 20; 55(86-87):1530-6. PubMed ID: 19102336
    [Abstract] [Full Text] [Related]

  • 6. [Coexpression and clinical significance of multi-drug resistance factors in lung cancer].
    Huo J, Che C, Huang Q.
    Zhongguo Fei Ai Za Zhi; 2004 Jun 20; 7(3):218-21. PubMed ID: 21232222
    [Abstract] [Full Text] [Related]

  • 7. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ, Yi YF.
    Ai Zheng; 2003 May 20; 22(5):496-9. PubMed ID: 12753710
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between expression of apoptosis-related genes and multidrug resistance genes in lung cancer tissues and their clinical significance].
    Zhang L, Yang H, Dong D.
    Zhongguo Fei Ai Za Zhi; 2007 Feb 20; 10(1):20-4. PubMed ID: 21110927
    [Abstract] [Full Text] [Related]

  • 9. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J, Zhang J, Zhang L, Zhao L, Fan S, Yang Z, Gao F, Kong Y, Xiao GG, Wang Q.
    Oncol Rep; 2011 Nov 20; 26(5):1081-9. PubMed ID: 21805041
    [Abstract] [Full Text] [Related]

  • 10. [Overexpression and its clinical significance of multi-drug resistance associated genes in lung cancer tissues].
    Li G, Dai J, Wang Y, Chen G, Liu X, Miao F, Bai L, Chen Y.
    Zhongguo Fei Ai Za Zhi; 2002 Feb 20; 5(1):35-7. PubMed ID: 21315026
    [Abstract] [Full Text] [Related]

  • 11. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP, Xiong YY, Tian SF.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar 20; 26(3):165-8. PubMed ID: 12816683
    [Abstract] [Full Text] [Related]

  • 12. [Expression of MDR1-mRNA, MRP-mRNA and LRP-mRNA in patients with non-small cell lung cancer].
    Yang J, Dai W, Shi T, Wei X.
    Zhongguo Fei Ai Za Zhi; 2001 Jun 20; 4(3):175-7. PubMed ID: 21047470
    [Abstract] [Full Text] [Related]

  • 13. Expression of multidrug resistance-related markers in primary neuroblastoma.
    Lu QJ, Dong F, Zhang JH, Li XH, Ma Y, Jiang WG.
    Chin Med J (Engl); 2004 Sep 20; 117(9):1358-63. PubMed ID: 15377429
    [Abstract] [Full Text] [Related]

  • 14. Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer.
    Zhu WY, Hunag YY, Liu XG, He JY, Chen DD, Zeng F, Zhou JH, Zhang YK.
    Anat Rec (Hoboken); 2012 Feb 20; 295(2):208-14. PubMed ID: 22190510
    [Abstract] [Full Text] [Related]

  • 15. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma].
    Leng WD, Wang DZ, Feng G, He J.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb 20; 22(1):23-5. PubMed ID: 15017692
    [Abstract] [Full Text] [Related]

  • 16. Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer: association with response to treatment and survival.
    Vlachogeorgos GS, Manali ED, Blana E, Legaki S, Karagiannidis N, Polychronopoulos VS, Roussos C.
    Cancer; 2008 Dec 25; 114(6):519-26. PubMed ID: 19006072
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
    Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K, Hara N.
    Cancer; 1996 Aug 01; 78(3):416-21. PubMed ID: 8697385
    [Abstract] [Full Text] [Related]

  • 18. Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer.
    Yu P, Du Y, Yang L, Fan S, Wu J, Zheng S.
    Int J Clin Exp Pathol; 2014 Aug 01; 7(11):7945-50. PubMed ID: 25550836
    [Abstract] [Full Text] [Related]

  • 19. Expression of multidrug resistance-related markers in gastric cancer.
    Fan K, Fan D, Cheng LF, Li C.
    Anticancer Res; 2000 Aug 01; 20(6C):4809-14. PubMed ID: 11205224
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T, Yasuda Y, Takaya T, Hayakawa K, Toshima S, Shibuya C, Kashiki Y, Yoshimi N, Shibayama M.
    Cancer Detect Prev; 2000 Aug 01; 24(3):252-7. PubMed ID: 10975287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.